Explore the latest NSCLC new treatments in development, including candidates aimed at tackling hard-to-treat, late-stage lung ...

We unpack the full scope of the U.S. budget cuts, from canceled clinical trials and stalled drug approvals to mass layoffs ...

Discover six hemophilia companies developing new treatments for the genetic bleeding disorder, from gene therapies to RNAi ...

Discover how early functional screening at the single-cell level transforms therapeutic development of your antibodies.

Find out how genome sequencing has emerged and what the future holds for one of biotech's most important tools.